📰 Distinguish Study News

Distinguish Study News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Distinguish Study. Real-time updates on events, politics, business and more.

Leap Therapeutics Reports Third Quarter 2023 Financial Results

November 13, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United Kingdom Matthew Deyoung Novarock Biotherapeutics Douglase Onsi Drug Administration Leap Therapeutics Inc

Source: prnewswire.com

Leap Therapeutics Reports Second Quarter 2023 Financial Results

August 14, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United States United Kingdom Douglase Onsi Matthew Deyoung Novarock Biotherapeutics Leap Therapeutics Inc

Source: prnewswire.com

Leap Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

March 24, 2023

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United Kingdom Matthew Deyoung Jason Baum Novarock Biotherapeutics Douglase Onsi Society For Immunotherapy Of Cancer

Source: prnewswire.com

Leap Therapeutics to Present Updated Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab and Preclinical Data in Colorectal Cancer Models at the SITC Annual Meeting

October 5, 2022

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today...

United States United Kingdom New Zealand Matthew Deyoung Douglase Onsi Prnewswire Leap Therapeutics Inc

Source: prnewswire.com

Leap Therapeutics Reports First Quarter 2022 Financial Results

May 13, 2022

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

New York United States United Kingdom New Zealand Matthew Deyoung Leica Biosystems

Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

March 11, 2022

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United Kingdom New Zealand Matthew Deyoung Leica Biosystems Douglase Onsi Beigene Ltd

Source: prnewswire.com

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

March 11, 2022

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United Kingdom New Zealand Matthew Deyoung Leica Biosystems Douglase Onsi Beigene Ltd

Source: prnewswire.com

Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming Data Presentation

August 13, 2021

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...

United States United Kingdom New Zealand South Korea Republic Of Korea Douglase Onsi

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Distinguish Study News Today

Stay Updated with Latest News

Explore More Categories